Stock Analysis of Mind Medicine Inc (MNMD) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code MNMD
Close 8.22
Change -0.430 / 4.97 %
Volume 1006.52 K
Vol Change -48820.00 / 4.63 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthNeutral
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Mind Medicine Inc
PE (TTM)

-1285.38

Very Poor
Price / Book

1327.98

Very Poor
Price / Sales

33294.80

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

590791 K

Enterprise Value

505216 K

ROA (TTM)

-74.66

Very Poor
ROE (TTM)

-103.31

Very Poor
Net Margin (TTM)

-2590.26

Very Poor
Revenue

%

0
Net Profit

35.17 %

-76771.00 K
Debt to Equity

0.181

Excellent
Altman Z Score

3.03

Good
Quick Ratio

0

Poor
Cash Ratio

3.09

Very Good


Highs/Lows of Mind Medicine Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week9.26 11.23 % 1.54 % 9.248.2213-May-2417-May-24
Two Week10.0 17.80 % 3.42 % 10.287.950106-May-2409-May-24
One Month9.53 13.75 % 5.60 % 10.347.950103-May-2409-May-24
Three Month4.92 67.07 % 5.95 % 12.224.504-Apr-2421-Feb-24
Six Months2.59 217.37 % 17.48 % 12.222.54504-Apr-2420-Nov-23
One year3.15 160.95 % 27.52 % 12.222.4104-Apr-2413-Nov-23
Two year11.616 29.24 % 29.70 % 12.222.1204-Apr-2429-Dec-22
Five year0.918 795.42 % 85.46 % 19.950.001518-Aug-2226-Dec-19


Technical View of Mind Medicine Inc
RSI

41.61

Neutral
MACD

-0.155

Bearish
ADX

17.81

Neutral
Super Trend

7.89

Mild Bullish
Williams %R

-88.71

Mild Bullish
CCI

-102.87

Mild Bullish


EMA 5

8.63

Strong Bearish
EMA 15

8.96

Mild Bearish
EMA 50

8.67

Whipsaw
EMA 100

7.46

Bullish
SMA 100

6.95

Bullish
SMA 200

5.17

Bullish
SMA 5 / 20

8.58 / 9.01

Bearish
SMA 15 / 50

9.14 / 9.44

Bearish
SMA 50 / 200

9.44 / 5.17

Strong Bullish




Charts of Mind Medicine Inc


Returns of Mind Medicine Inc with Peers
Period / StockMNMDHROWAVTEPETQ
1 Week-11.23%44.48%3.73%8.30%
1 Mth-13.75%41.79%-8.58%25.36%
3 Mth67.07%57.08%-1.63%6.00%
6mth217.37%87.05%41.96%9.13%
1 Year160.95%-22.44%5.70%57.24%
2 Year-29.24%189.97%67.92%17.54%
5 Years795.42%174.30%--30.15%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Mind Medicine Inc with Peers
Ratio / StockMNMDHROWAVTEPETQ
PE-1285.38-18.11-6.9321.00
P/B1327.9811.394.902.30
ROA-74.66-11.74-62.712.95
ROE-103.31-62.43-70.7210.98
Debt To Equity0.1812.610.00382.05
Revenue0
% 		114167 K
28.86 % 		0
% 		1101.96 K
99.88 %
Net Income-76771.00 K
35.17 % 		-14208.00 K
0.866 % 		-70130.00 K
36.15 % 		2131.00
100.00 %


Technicals of Mind Medicine Inc with Peers
Technical / StockMNMDHROWAVTEPETQ-
ADX17.8131.1413.9433.30
CMF0.0750.02040.0650.210
MFI45.3982.5060.5077.84
RSI41.6177.6544.8675.89
MACD Abv SignalFalseTrueTrueTrue
Price Above 50 MAFalseTrueFalseTrue-
Price Above 200 MATrueTrueTrueTrue-


About : Mind Medicine Inc

Address : One World Trade Center, New York, NY, United States, 10007
Tel : 212-220-6633
URL : https://www.mindmed.co
Code : MNMD, ISIN : CA60255C8850, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 03_Mar_2020
Employee Count : 57

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.


Note : All Data Generated at the End of Trading Hours (EOD Data)